Targeted Therapies in Oncology
July 2
Volume: 8
Issue: 10
June 2019
Volume: 8
Issue: 8
May 2019
Volume: 8
Issue: 7
April 2 2019
Volume: 8
Issue: 6
April 2019
Volume: 8
Issue: 5
March 2019
Volume: 8
Issue: 4
February 2 2019
Volume: 8
Issue: 3
February 2019
Volume: 8
Issue: 2
January 2019
Volume: 8
Issue: 1
December 2 2018
Volume: 7
Issue: 13
December 2018
Volume: 7
Issue: 12
November 2018
Volume: 7
Issue: 11
October 2018
Volume: 7
Issue: 10
Sept 2018
Volume: 7
Issue: 9
August 2018
Volume: 7
Issue: 8
July 2018
Volume: 7
Issue: 7
June 2018
Volume: 7
Issue: 6
May 2018
Volume: 7
Issue: 5
April 2018
Volume: 7
Issue: 4
March 2018
Volume: 7
Issue: 3
February 2018
Volume: 7
Issue: 2
January 2018
Volume: 7
Issue: 1
December 2017
Volume: 6
Issue: 12
November 2017
Volume: 6
Issue: 11
October 2017
Volume: 6
Issue: 10
September 2017
Volume: 6
Issue: 9
August 2017
Volume: 6
Issue: 8
July 2017
Volume: 6
Issue: 7
June 2017
Volume: 6
Issue: 6
May 2017
Volume: 6
Issue: 5
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Pirtobrutinib Gains FDA Approval for Frontline CLL/SLL in Select Patients
2
Ubamatamab Shows Durable Responses in Low-Grade Serous Ovarian Cancer
3
NDA Submission Initiated for Zipalertinib Combo in EGFR Exon 20+ NSCLC
4
What Stood Out at IMS 2026? Five Myeloma Experts Weigh In
5